REGULATORY REVIEW: History of Prescription Drug Regulation


History of Prescription Drug Regulation

What this means for future rulemaking

In an October 2018 poll conducted by the Kaiser Family Foundation (KFF), healthcare was the most important issue among registered voters, and healthcare costs, including prescription drugs, was listed as the most important issue within healthcare. A follow-up KFF poll conducted in March 2019 found that 79 percent of respondents viewed the costs of prescription drugs as unreasonable and showed broad bipartisan support for a number of drug-related reforms. This discontent has not gone unnoticed by politicians: in May 2018, the Trump administration released its American Patients First blueprint, a broad plan to lower the cost of prescription drugs and reduce patient out-of-pocket expenses.

To read this article, you have to be a member of ASCA or subscribe to ASC Focus magazine.

Sign in > Join >Subscribe >